Health Trials

Does Recessive Optic Atrophy Due to WFS1 Exist?

ConditionsWolfram Syndrome 1Optic Atrophies, Hereditary
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeNot listed
SponsorHôpital Necker-Enfants Malades

About this trial

All patients with Wolfram syndrome and recessive optic atrophy due to a mutation of the WFS1 from a single Center were included in a retrospective study. Evolution of the visual acuity since the occurrence of the optic atrophy and its last value, OCT data, genetic data and systemic manifestations were analyzed.

Eligibility criteria

Qualifiers

WFS1 mutation

Disqualifiers

WFS2 mutation

Trial design

Treatments tested in this trial

  • analyse study

Treatment groups

45 Participants
are divided into 2 treatment groups

Locations

This trial has no locations

Sponsors and collaborators

Hôpital Necker-Enfants Malades

Lead sponsor

European Georges Pompidou Hospital

Sponsor institution

Source ClinicalTrials.gov